Pregnancy After Breast Cancer in Young BRCA Carriers
JAMA · 02.01.2024 · 331 (1) · 49
DOI: 10.1001/jama.2023.25463 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA, erschienen am 02.01.2024. Verfasst von Matteo Lambertini und 54 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Genes, BRCA2, Genes, BRCA1, Pregnancy Outcome. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Importance Young women with breast cancer who have germline pathogenic variants in BRCA1 or BRCA2 face unique challenges regarding fertility. Previous studies demonstrating the feasibility and safety of pregnancy in breast cancer survivors included limited data regarding BRCA carriers.
Objective
To investigate cumulative incidence of pregnancy and disease-free survival in young women who are BRCA carriers. Design, Setting, and Participants International, multicenter, hospital-based, retrospective cohort study conducted at 78 participating centers worldwide. The study included female participants diagnosed with invasive breast cancer at age 40 years or younger between January 2000 and December 2020 carrying germline pathogenic variants in BRCA1 and/or BRCA2 . Last delivery was October 7, 2022; last follow-up was February 20, 2023. Exposure Pregnancy after breast cancer. Main Outcomes and Measures Primary end points were cumulative incidence of pregnancy after breast cancer and disease-free survival. Secondary end points were breast cancer–specific survival, overall survival, pregnancy, and fetal and obstetric outcomes.
Results
Of 4732 BRCA carriers included, 659 had at least 1 pregnancy after breast cancer and 4073 did not. Median age at diagnosis in the overall cohort was 35 years (IQR, 31-38 years). Cumulative incidence of pregnancy at 10 years was 22% (95% CI, 21%-24%), with a median time from breast cancer diagnosis to conception of 3.5 years (IQR, 2.2-5.3 years). Among the 659 patients who had a pregnancy, 45 (6.9%) and 63 (9.7%) had an induced abortion or a miscarriage, respectively. Of the 517 patients (79.7%) with a completed pregnancy, 406 (91.0%) delivered at term (≥37 weeks) and 54 (10.4%) had twins. Among the 470 infants born with known information on pregnancy complications, 4 (0.9%) had documented congenital anomalies. Median follow-up was 7.8 years (IQR, 4.5-12.6 years). No significant difference in disease-free survival was observed between patients with or without a pregnancy after breast cancer (adjusted hazard ratio, 0.99; 95% CI, 0.81-1.20). Patients who had a pregnancy had significantly better breast cancer–specific survival and overall survival. Conclusions and Relevance In this global study, 1 in 5 young BRCA carriers conceived within 10 years after breast cancer diagnosis. Pregnancy following breast cancer in BRCA carriers was not associated with decreased disease-free survival. Trial Registration ClinicalTrials.gov Identifier: NCT03673306
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy.
- Department of Medical Oncology, U. O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
- U. O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
- Breast Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium.
- Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France.
- Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Förderung
- NCATS NIH HHS
- NCI NIH HHS
Zitieren
APA
Lambertini, M., Blondeaux, E., Agostinetto, E., Hamy, A. S., Kim, H. J., Di Meglio, A., Bernstein Molho, R., Hilbers, F., Pogoda, K., Carrasco, E., Punie, K., Bajpai, J., Ignatiadis, M., Moore, H. C. F., Phillips, K. A., Toss, A., Rousset-Jablonski, C., Peccatori, F. A., Renaud, T., …, & BRCA BCY Collaboration (2024). Pregnancy After Breast Cancer in Young BRCA Carriers. JAMA, 331(1), 49. https://doi.org/10.1001/jama.2023.25463
Vancouver
Lambertini M, Blondeaux E, Agostinetto E, Hamy AS, Kim HJ, Di Meglio A, et al. Pregnancy After Breast Cancer in Young BRCA Carriers. JAMA. 2024;331(1):49. doi:10.1001/jama.2023.25463
BibTeX
@article{Lambertini2024,
author = {Lambertini, Matteo and Blondeaux, Eva and Agostinetto, Elisa and Hamy, Anne-Sophie and Kim, Hee Jeong and Di Meglio, Antonio and Bernstein Molho, Rinat and Hilbers, Florentine and Pogoda, Katarzyna and Carrasco, Estela and Punie, Kevin and Bajpai, Jyoti and Ignatiadis, Michail and Moore, Halle C F and Phillips, Kelly-Anne and Toss, Angela and Rousset-Jablonski, Christine and Peccatori, Fedro A and Renaud, Tiphaine and Ferrari, Alberta and Paluch-Shimon, Shani and Fruscio, Robert and Cui, Wanda and Wong, Stephanie M and Vernieri, Claudio and Ruddy, Kathryn J and Dieci, Maria Vittoria and Matikas, Alexios and Rozenblit, Mariya and Villarreal-Garza, Cynthia and De Marchis, Laura and Del Mastro, Lucia and Puglisi, Fabio and Del Pilar Estevez-Diz, Maria and Rodriguez-Wallberg, Kenny A and Mrinakova, Bela and Meister, Sarah and Livraghi, Luca and Clatot, Florian and Yerushalmi, Rinat and De Angelis, Carmine and Sánchez-Bayona, Rodrigo and Meattini, Icro and Cichowska-Cwalinska, Natalia and Berlière, Martine and Salama, Mahmoud and De Giorgi, Ugo and Sonnenblick, Amir and Chiodi, Camila and Lee, Young-Jin and Maria, Camille and Azim, Hatem A and Boni, Luca and Partridge, Ann H and BRCA BCY Collaboration, BRCA BCY Collaboration},
title = {Pregnancy After Breast Cancer in Young BRCA Carriers},
journal = {JAMA},
year = {2024},
volume = {331},
number = {1},
pages = {49},
doi = {10.1001/jama.2023.25463}
}
EUVIMED